Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Chiorazzi

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
Nucleic Acids Research|February 22, 2020
Multiplex accurate sensitive quantitation (MASQ) with application to minimal residual disease in acute myeloid leukemiaAndrea B Moffitt, Mona S Spector, Peter Andrews, et al.
Oncotarget|March 31, 2016
A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cellsBurcu Yigit, Peter J Halibozek, Shih-Shih Chen, et al.
Leukemia & Lymphoma|September 20, 2013
Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemiaJane Houldsworth, Asha Guttapalli, Venkata Thodima, et al.
Frontiers in Oncology|April 3, 2023
CLL stereotyped B-cell receptor immunoglobulin sequences are recurrent in the B-cell repertoire of healthy individuals: Apparent lack of central and early peripheral tolerance censoringStefano Vergani, Davide Bagnara, Andreas Agathangelidis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Colocalization of antigen-specific B and T cells within ectopic lymphoid tissue following immunization with exogenous antigenJason S Weinstein, Dina C Nacionales, Pui Y Lee, et al.
Nature Communications|June 10, 2017
Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemiaClaudia Minici, Maria Gounari, Rudolf Übelhart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2017
Combined BTK and PI3Kδ Inhibition with Acalabrutinib and ACP-319 Improves Survival and Tumor Control in CLL Mouse ModelCarsten U Niemann, Helena I Mora-Jensen, Eman L Dadashian, et al.
JCI Insight|May 5, 2022
Activated CLL cells regulate IL-17F-producing Th17 cells in miR155-dependent and outcome-specific mannersByeongho Jung, Gerardo Ferrer, Pui Yan Chiu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2015
TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B CellsPatricia K A Mongini, Rashmi Gupta, Erin Boyle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2013
Igs expressed by chronic lymphocytic leukemia B cells show limited binding-site structure variabilityPaolo Marcatili, Fabio Ghiotto, Claudya Tenca, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
Nucleic Acids Research|February 22, 2020
Multiplex accurate sensitive quantitation (MASQ) with application to minimal residual disease in acute myeloid leukemiaAndrea B Moffitt, Mona S Spector, Peter Andrews, et al.
Oncotarget|March 31, 2016
A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cellsBurcu Yigit, Peter J Halibozek, Shih-Shih Chen, et al.
Leukemia & Lymphoma|September 20, 2013
Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemiaJane Houldsworth, Asha Guttapalli, Venkata Thodima, et al.
Frontiers in Oncology|April 3, 2023
CLL stereotyped B-cell receptor immunoglobulin sequences are recurrent in the B-cell repertoire of healthy individuals: Apparent lack of central and early peripheral tolerance censoringStefano Vergani, Davide Bagnara, Andreas Agathangelidis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Colocalization of antigen-specific B and T cells within ectopic lymphoid tissue following immunization with exogenous antigenJason S Weinstein, Dina C Nacionales, Pui Y Lee, et al.
Nature Communications|June 10, 2017
Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemiaClaudia Minici, Maria Gounari, Rudolf Übelhart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2017
Combined BTK and PI3Kδ Inhibition with Acalabrutinib and ACP-319 Improves Survival and Tumor Control in CLL Mouse ModelCarsten U Niemann, Helena I Mora-Jensen, Eman L Dadashian, et al.
JCI Insight|May 5, 2022
Activated CLL cells regulate IL-17F-producing Th17 cells in miR155-dependent and outcome-specific mannersByeongho Jung, Gerardo Ferrer, Pui Yan Chiu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2015
TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B CellsPatricia K A Mongini, Rashmi Gupta, Erin Boyle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2013
Igs expressed by chronic lymphocytic leukemia B cells show limited binding-site structure variabilityPaolo Marcatili, Fabio Ghiotto, Claudya Tenca, et al.
Pageof 17